CHCHD2 and Parkinson disease: Hence, when it comes to mediating pathological changes in CHCHD2-associated PD, the interaction of CHCHD2 with SLC25A4 (ANT1), GHITM, and NME4 may be more relevant than its previously proposed interaction with MICOS in (Fig. 6, in pink).